Heparin-resistance in AL amyloidosis: a case report

Elisabeth S van Ede, Marlijn P A Hoeks, Jan Hofland, Vera D Linssen*, Toin H van Kuppevelt, Elly M Versteeg, Theo G Hafmans, Arjan Diepstra, Benno Kusters, Sanne M M Vermorgen

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    1 Citation (Scopus)
    79 Downloads (Pure)

    Abstract

    BACKGROUND: Non-AT-III mediated heparin-resistance during CPB occurs by complex-forming with heparin-binding proteins. Currently, there are no specific recommendations for non-AT-III mediated heparin-resistance.

    CASE PRESENTATION: We present a fatal case of a 70-yr-old male-patient undergoing cardiac-surgery in which refractory heparin-resistance was observed. The massive AL amyloidosis found at autopsy is thought to be responsible and illustrates that awareness and knowledge of the etiology and perioperative strategies of non-AT-III mediated heparin-resistance is important.

    CONCLUSION: For anticoagulation during cardiopulmonary bypass surgery in case of a non-AT-III medicated heparin resistance, we refer to the decision tree added to this manuscript and if necessary to consider direct thrombin inhibitors, such as bivalirudin or argatroban, as it bypasses the complexing pathway.

    Original languageEnglish
    Article number217
    Number of pages7
    JournalBMC Anesthesiology
    Volume23
    DOIs
    Publication statusPublished - 21-Jun-2023

    Keywords

    • Humans
    • Heparin/therapeutic use
    • Anticoagulants/therapeutic use
    • Immunoglobulin Light-chain Amyloidosis/drug therapy
    • Cardiac Surgical Procedures
    • Peptide Fragments
    • Cardiopulmonary Bypass

    Fingerprint

    Dive into the research topics of 'Heparin-resistance in AL amyloidosis: a case report'. Together they form a unique fingerprint.

    Cite this